1 Effect of Blast Exposure on Gene-Gene Interactions Akram
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Glioblastomas with Copy Number Gains in EGFR and RNF139 Show Increased Expressions of Carbonic Anhydrase Genes Transformed by ENO1
BBA Clinical 5 (2016) 1–15 Contents lists available at ScienceDirect BBA Clinical journal homepage: www.elsevier.com/locate/bbaclin Glioblastomas with copy number gains in EGFR and RNF139 show increased expressions of carbonic anhydrase genes transformed by ENO1 Marie E. Beckner a,⁎,2, Ian F. Pollack b,c,MaryL.Nordbergd,e, Ronald L. Hamilton f a Department of Neurology, Louisiana State University Health Sciences Center-Shreveport, RM. 3-438, 1501 Kings Highway, Shreveport, LA 71130, United States 1 b Department of Neurological Surgery, University of Pittsburgh School of Medicine, United States c 4th Floor, Children's Hospital of Pittsburgh, UPMC, 4129 Penn Avenue, Pittsburgh, PA 15224, United States d Department of Medicine, Louisiana State University Health, 1501 Kings Highway, Shreveport, LA 71130, United States e The Delta Pathology Group, One Saint Mary Place, Shreveport, LA 71101, United States f Department of Pathology, Division of Neuropathology, S724.1, Scaife Hall, University of Pittsburgh School of Medicine, 3550 Terrace Street, Pittsburgh, PA 15261, United States article info abstract Article history: Background: Prominence of glycolysis in glioblastomas may be non-specific or a feature of oncogene-related Received 12 August 2015 subgroups (i.e. amplified EGFR, etc.). Relationships between amplified oncogenes and expressions of metabolic Received in revised form 17 October 2015 genes associated with glycolysis, directly or indirectly via pH, were therefore investigated. Accepted 2 November 2015 Methods: Using multiplex ligation-dependent probe amplification, copy numbers (CN) of 78 oncogenes were Available online 10 November 2015 quantified in 24 glioblastomas. Related expressions of metabolic genes encoding lactate dehydrogenases (LDHA, LDHC), carbonic anhydrases (CA3, CA12), monocarboxylate transporters (SLC16A3 or MCT4, SLC16A4 or Keywords: MCT5), ATP citrate lyase (ACLY), glycogen synthase1 (GYS1), hypoxia inducible factor-1A (HIF1A), and enolase1 Amplified oncogenes Glycolysis (ENO1) were determined in 22 by RT-qPCR. -
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
BRI2 (Itm2b) Inhibits A Deposition in Vivo
6030 • The Journal of Neuroscience, June 4, 2008 • 28(23):6030–6036 Neurobiology of Disease BRI2 (ITM2b) Inhibits A Deposition In Vivo Jungsu Kim,1 Victor M. Miller,1 Yona Levites,1 Karen Jansen West,1 Craig W. Zwizinski,1 Brenda D. Moore,1 Fredrick J. Troendle,1 Maralyssa Bann,1 Christophe Verbeeck,1 Robert W. Price,1 Lisa Smithson,1 Leilani Sonoda,1 Kayleigh Wagg,1 Vijayaraghavan Rangachari,1 Fanggeng Zou,1 Steven G. Younkin,1 Neill Graff-Radford,2 Dennis Dickson,1 Terrone Rosenberry,1 and Todd E. Golde1 Departments of 1Neuroscience and 2Neurology, Mayo Clinic College of Medicine, Mayo Clinic Jacksonville, Jacksonville, Florida 32224 AnalysesofthebiologiceffectsofmutationsintheBRI2(ITM2b)andtheamyloidprecursorprotein(APP)genessupportthehypothesis that cerebral accumulation of amyloidogenic peptides in familial British and familial Danish dementias and Alzheimer’s disease (AD) is associatedwithneurodegeneration.WehaveusedsomaticbraintransgenictechnologytoexpresstheBRI2andBRI2-A1–40transgenes in APP mouse models. Expression of BRI2-A1–40 mimics the suppressive effect previously observed using conventional transgenic methods, further validating the somatic brain transgenic methodology. Unexpectedly, we also find that expression of wild-type human BRI2 reduces cerebral A deposition in an AD mouse model. Additional data indicate that the 23 aa peptide, Bri23, released from BRI2 by normal processing, is present in human CSF, inhibits A aggregation in vitro and mediates its anti-amyloidogenic effect in vivo. These studies demonstrate that BRI2 is a novel mediator of A deposition in vivo. Key words: BRI2; ITM2b; amyloid  protein; Alzheimer’s disease; somatic brain transgenesis; adeno-associated virus Introduction pathological and clinical similarities between FBD, FDD, and Familial British and Danish dementias (FBD and FDD, respec- Alzheimer’s disease (AD). -
Cerebral Amyloidosis, Amyloid Angiopathy, and Their Relationship to Stroke and Dementia
65 Cerebral amyloidosis, amyloid angiopathy, and their relationship to stroke and dementia ∗ Jorge Ghiso and Blas Frangione β-pleated sheet structure, the conformation responsi- Department of Pathology, New York University School ble for their physicochemical properties and tinctoreal of Medicine, New York, NY, USA characteristics. So far, 20 different proteins have been identified as subunits of amyloid fibrils [56,57,60 (for review and nomenclature)]. Although collectively they Cerebral amyloid angiopathy (CAA) is the common term are products of normal genes, several amyloid precur- used to define the deposition of amyloid in the walls of sors contain abnormal amino acid substitutions that can medium- and small-size leptomeningeal and cortical arteries, arterioles and, less frequently, capillaries and veins. CAA impose an unusual potential for self-aggregation. In- is an important cause of cerebral hemorrhages although it creased levels of amyloid precursors, either in the cir- may also lead to ischemic infarction and dementia. It is a culation or locally at sites of deposition, are usually the feature commonly associated with normal aging, Alzheimer result of overexpression, defective clearance, or both. disease (AD), Down syndrome (DS), and Sporadic Cerebral Of all the amyloid proteins identified, less than half are Amyloid Angiopathy. Familial conditions in which amyloid known to cause amyloid deposition in the central ner- is chiefly deposited as CAA include hereditary cerebral hem- vous system (CNS), which in turn results in cognitive orrhage with amyloidosis of Icelandic type (HCHWA-I), fa- decline, dementia, stroke, cerebellar and extrapyrami- milial CAA related to Aβ variants, including hereditary cere- dal signs, or a combination of them. -
Article Reference
Article The tumor suppressor gene TRC8/RNF139 is disrupted by a constitutional balanced translocation t(8;22)(q24.13;q11.21) in a young girl with dysgerminoma GIMELLI, Stefania, et al. Abstract BACKGROUND: RNF139/TRC8 is a potential tumor suppressor gene with similarity to PTCH, a tumor suppressor implicated in basal cell carcinomas and glioblastomas. TRC8 has the potential to act in a novel regulatory relationship linking the cholesterol/lipid biosynthetic pathway with cellular growth control and has been identified in families with hereditary renal (RCC) and thyroid cancers. Haploinsufficiency of TRC8 may facilitate development of clear cell-RCC in association with VHL mutations, and may increase risk for other tumor types. We report a paternally inherited balanced translocation t(8;22) in a proposita with dysgerminoma. METHODS: The translocation was characterized by FISH and the breakpoints cloned, sequenced, and compared. DNA isolated from normal and tumor cells was checked for abnormalities by array-CGH. Expression of genes TRC8 and TSN was tested both on dysgerminoma and in the proposita and her father. RESULTS: The breakpoints of the translocation are located within the LCR-B low copy repeat on chromosome 22q11.21, containing the palindromic AT-rich repeat (PATRR) involved in recurrent and non-recurrent [...] Reference GIMELLI, Stefania, et al. The tumor suppressor gene TRC8/RNF139 is disrupted by a constitutional balanced translocation t(8;22)(q24.13;q11.21) in a young girl with dysgerminoma. Molecular Cancer, 2009, vol. 8, p. 52 DOI : 10.1186/1476-4598-8-52 PMID : 19642973 Available at: http://archive-ouverte.unige.ch/unige:5661 Disclaimer: layout of this document may differ from the published version. -
Unbiased RNA-Seq-Driven Identification and Validation Of
Dai et al. BMC Genomics (2021) 22:27 https://doi.org/10.1186/s12864-020-07318-y RESEARCH ARTICLE Open Access Unbiased RNA-Seq-driven identification and validation of reference genes for quantitative RT-PCR analyses of pooled cancer exosomes Yao Dai1, Yumeng Cao1, Jens Köhler2, Aiping Lu1, Shaohua Xu1* and Haiyun Wang1* Abstract Background: Exosomes are extracellular vesicles (EVs) derived from endocytic compartments of eukaryotic cells which contain various biomolecules like mRNAs or miRNAs. Exosomes influence the biologic behaviour and progression of malignancies and are promising candidates as non-invasive diagnostic biomarkers or as targets for therapeutic interventions. Usually, quantitative real-time polymerase chain reaction (qRT-PCR) is used to assess gene expression in cancer exosomes, however, the ideal reference genes for normalization yet remain to be identified. Results: In this study, we performed an unbiased analysis of high-throughput mRNA and miRNA-sequencing data from exosomes of patients with various cancer types and identify candidate reference genes and miRNAs in cancer exosomes. The expression stability of these candidate reference genes was evaluated by the coefficient of variation “CV” and the average expression stability value “M”. We subsequently validated these candidate reference genes in exosomes from an independent cohort of ovarian cancer patients and healthy control individuals by qRT-PCR. Conclusions: Our study identifies OAZ1 and hsa-miR-6835-3p as the most reliable individual reference genes for mRNA and miRNA quantification, respectively. For superior accuracy, we recommend the use of a combination of reference genes - OAZ1/SERF2/MPP1 for mRNA and hsa-miR-6835-3p/hsa-miR-4468-3p for miRNA analyses. -
Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in -
Studies of Amyloid Toxicity in Drosophila Models and Effects of the Brichos Domain
From The Department of Neurobiology, Care Sciences and Society Karolinska Institutet, Stockholm, Sweden STUDIES OF AMYLOID TOXICITY IN DROSOPHILA MODELS AND EFFECTS OF THE BRICHOS DOMAIN Erik Hermansson Wik Stockholm 2015 All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by E-print AB 2015 © Erik Hermansson Wik, 2015 ISBN 978-91-7549-955-0 Studies of amyloid toxicity in Drosophila models and effects of the BRICHOS domain THESIS FOR DOCTORAL DEGREE (Ph.D.) By Erik Hermansson Wik Principal Supervisor: Opponent: Professor Jan Johansson Professor Harm H. Kampinga Karolinska Institutet University of Groningen Department of Neurobiology, Care Sciences and Department of Cell Biology Society Division of Neurogeriatrics Examination Board: Associate Professor Joakim Bergström Co-supervisors: Uppsala University Dr Jenny Presto Department of Public Health and Caring Sciences Karolinska Institutet Department of Neurobiology, Care Sciences and Professor Ylva Engström Society Stockholm University Division of Neurogeriatrics Department of Molecular Biosciences, The Wenner-Gren Institute Professor Gunilla Westermark Uppsala University Associate Professor Åsa Winther Department of Medical Cell Biology Karolinska Institutet Department of Neuroscience To my family ABSTRACT Amyloid diseases involve specific protein misfolding events and formation of fibrillar deposits. The symptoms of these diseases are broad and dependent on site of accumulation, with different amyloid proteins depositing in specific tissues or systematically. One such protein is transthyretin (TTR) associated with senile systemic amyloidosis, familial amyloid polyneuropathy and familial amyloid cardiomyopathy. We show that the glycosaminoglycan heparan sulfate (HS) can be co-localized with TTR in elder myopathic heart tissue and identify residue 24-35 of TTR as the binding site of HS. -
Protein Quality Control in the ER: Balancing the Ubiquitin Chequebook Coverdesign By: Jasper Claessen
Protein quality control in the ER: balancing the ubiquitin chequebook Coverdesign by: Jasper Claessen Copyright © 2012 Jasper Claessen. No part of this thesis may be reproduced, stored, or transmitted in any form or by any means, without permission of the au- thor. The research described in this thesis was conducted at the Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, USA, under the supervision of Prof. Dr. H.L. Ploegh. Printed by Gildeprint B.V., Enschede, the Netherlands ISBN: 978-94-6108-316-6 Protein quality control in the ER: balancing the ubiquitin chequebook Kwaliteits-kontrole voor eiwitten in het ER: het opmaken van de ubiquitine balans (met een samenvatting in het Nederlands) Proefschrift ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de rector magnificus, prof.dr. G.J. van der Zwaan, ingevolge het besluit van het college voor promoties in het openbaar te verdedigen op donderdag 5 juli des ochtends te 10.30 uur door Jasper Henri Laurens Claessen geboren op 21 mei 1984 te Hardenberg Promotiecommissie Promotoren: Prof. Dr. H.L. Ploegh Prof. Dr. E.J.H.J. Wiertz Overige leden: Prof. Dr. J. Klumperman Prof. Dr. I. Braakman Prof. Dr. J. Boonstra Prof. Dr. A. Heck Dr. M. Maurice Dr. F. Reggiori Table of contents Chapter 1: General Introduction Page 9 Chapter 2: The Transmembrane Domain of a Page 41 Tail-anchored Protein Determines Its Degradative Fate through Dislocation from the Endoplasmic Reticulum Chapter 3: Enzymatic Blockade of the Ubiquitin-Proteasome -
High-Resolution Acgh and Expression Profiling Identifies a Novel Genomic
Open Access Research2007ChinetVolume al. 8, Issue 10, Article R215 High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer Suet F Chin¤*, Andrew E Teschendorff¤*†, John C Marioni¤†§, Yanzhong Wang*, Nuno L Barbosa-Morais†, Natalie P Thorne†§, Jose L Costa#, Sarah E Pinder¥, Mark A van de Wiel**††, Andrew R Green¶, Ian O Ellis¶, Peggy L Porter‡‡, Simon Tavar醧, James D Brenton‡, Bauke Ylstra# and Carlos Caldas*¥ Addresses: *Breast Cancer Functional Genomics, Cancer Research UK Cambridge Research Institute and Department of Oncology University of Cambridge, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. †Computational Biology Group, Cancer Research UK Cambridge Research Institute and Department of Oncology University of Cambridge, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. ‡Functional Genomics of Drug Resistance, Cancer Research UK Cambridge Research Institute and Department of Oncology University of Cambridge, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. §Computational Biology Group, Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Centre for Mathematical Sciences, Wilberforce Road, Cambridge CB3 0WA, UK. ¶Histopathology, Nottingham City Hospital NHS Trust and University of Nottingham, Nottingham NG5 1PB, UK. ¥Cambridge Breast Unit, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. #Department of Pathology, VU University Medical Center, PO Box 7057, 1007MB Amsterdam, The Netherlands. **Department of Biostatistics, VU University Medical Center, PO Box 7057, 1007MB Amsterdam, The Netherlands. ††Department of Mathematics, Vrije Universiteit, Amsterdam, Netherlands. ‡‡Division of Human Biology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. -
Hereditary Cerebral Amyloid Angiopathy
Hereditary cerebral amyloid angiopathy Description Hereditary cerebral amyloid angiopathy is a condition that can cause a progressive loss of intellectual function (dementia), stroke, and other neurological problems starting in mid-adulthood. Due to neurological decline, this condition is typically fatal in one's sixties, although there is variation depending on the severity of the signs and symptoms. Most affected individuals die within a decade after signs and symptoms first appear, although some people with the disease have survived longer. There are many different types of hereditary cerebral amyloid angiopathy. The different types are distinguished by their genetic cause and the signs and symptoms that occur. The various types of hereditary cerebral amyloid angiopathy are named after the regions where they were first diagnosed. The Dutch type of hereditary cerebral amyloid angiopathy is the most common form. Stroke is frequently the first sign of the Dutch type and is fatal in about one third of people who have this condition. Survivors often develop dementia and have recurrent strokes. About half of individuals with the Dutch type who have one or more strokes will have recurrent seizures (epilepsy). People with the Flemish and Italian types of hereditary cerebral amyloid angiopathy are prone to recurrent strokes and dementia. Individuals with the Piedmont type may have one or more strokes and typically experience impaired movements, numbness or tingling (paresthesias), confusion, or dementia. The first sign of the Icelandic type of hereditary cerebral amyloid angiopathy is typically a stroke followed by dementia. Strokes associated with the Icelandic type usually occur earlier than the other types, with individuals typically experiencing their first stroke in their twenties or thirties. -
UC Riverside UC Riverside Previously Published Works
UC Riverside UC Riverside Previously Published Works Title Identifying potential cancer driver genes by genomic data integration. Permalink https://escholarship.org/uc/item/9m3339bm Journal Scientific reports, 3(1) ISSN 2045-2322 Authors Chen, Yong Hao, Jingjing Jiang, Wei et al. Publication Date 2013-12-18 DOI 10.1038/srep03538 Peer reviewed eScholarship.org Powered by the California Digital Library University of California OPEN Identifying potential cancer driver genes SUBJECT AREAS: by genomic data integration CANCER GENOMICS Yong Chen1,2, Jingjing Hao2, Wei Jiang2, Tong He3, Xuegong Zhang2, Tao Jiang2,4 & Rui Jiang2 COMPUTATIONAL BIOLOGY AND BIOINFORMATICS 1National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China, 2MOE Key Laboratory of Bioinformatics and Bioinformatics Division, TNLIST/Department of Automation, Tsinghua University, Beijing 3 Received 100084, China, School of Applied Mathematics, Central University of Finance and Economics, Beijing 102206, China, 4 17 September 2013 Department of Computer Science and Engineering, University of California, Riverside, CA 92521, USA. Accepted 2 December 2013 Cancer is a genomic disease associated with a plethora of gene mutations resulting in a loss of control over vital cellular functions. Among these mutated genes, driver genes are defined as being causally linked to Published oncogenesis, while passenger genes are thought to be irrelevant for cancer development. With increasing 18 December 2013 numbers of large-scale genomic datasets available, integrating these genomic data to identify driver genes from aberration regions of cancer genomes becomes an important goal of cancer genome analysis and investigations into mechanisms responsible for cancer development. A computational method, MAXDRIVER, is proposed here to identify potential driver genes on the basis of copy number aberration Correspondence and (CNA) regions of cancer genomes, by integrating publicly available human genomic data.